Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Perispinal etanercept for neuroinflammatory disorders.

Tobinick E.

Drug Discov Today. 2009 Feb;14(3-4):168-77. doi: 10.1016/j.drudis.2008.10.005. Epub 2008 Dec 6. Review.

PMID:
19027875
2.

Perispinal etanercept for treatment of Alzheimer's disease.

Tobinick E.

Curr Alzheimer Res. 2007 Dec;4(5):550-2. Review.

PMID:
18220520
3.

Perispinal etanercept: a new therapeutic paradigm in neurology.

Tobinick E.

Expert Rev Neurother. 2010 Jun;10(6):985-1002. doi: 10.1586/ern.10.52. Review. Erratum in: Expert Rev Neurother. 2010 Jul;10(7):1232.

PMID:
20518613
4.
5.

Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Tobinick E.

CNS Drugs. 2009 Sep;23(9):713-25. doi: 10.2165/11310810-000000000-00000. Review.

PMID:
19689163
6.

Anti-TNF-alpha therapies in chronic obstructive pulmonary diseases.

Antoniu SA, Mihaltan F, Ulmeanu R.

Expert Opin Investig Drugs. 2008 Aug;17(8):1203-11. doi: 10.1517/13543784.17.8.1203 . Review.

PMID:
18616416
7.

Targeting tumour necrosis factor-alpha in corticosteroid-dependent asthma.

Antoniu SA.

Expert Opin Ther Targets. 2006 Jun;10(3):471-3. Review.

PMID:
16706686
8.

Etanercept associated optic neuropathy.

Chang V, McCurdy D, Gordon LK.

Clin Exp Ophthalmol. 2007 Sep-Oct;35(7):680-2. Review.

PMID:
17894694
9.

The effect of tumor necrosis factor antagonists on mood and mental health-associated quality of life: novel hypothesis-driven treatments for bipolar depression?

Soczynska JK, Kennedy SH, Goldstein BI, Lachowski A, Woldeyohannes HO, McIntyre RS.

Neurotoxicology. 2009 Jul;30(4):497-521. doi: 10.1016/j.neuro.2009.03.004. Epub 2009 Mar 24. Review.

PMID:
19477018
10.

Non-steroidal anti-inflammatory drugs as anti-amyloidogenic compounds.

Hirohata M, Ono K, Yamada M.

Curr Pharm Des. 2008;14(30):3280-94. Review.

PMID:
19075706
11.

Perispinal Delivery of CNS Drugs.

Tobinick EL.

CNS Drugs. 2016 Jun;30(6):469-80. doi: 10.1007/s40263-016-0339-2. Review.

12.

Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.

Tuttolomondo A, Pecoraro R, Pinto A.

Drug Des Devel Ther. 2014 Nov 7;8:2221-38. doi: 10.2147/DDDT.S67655. eCollection 2014. Review.

13.

TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2009;16(24):3152-67. Review.

PMID:
19689289
14.

Targeting TNF: a therapeutic strategy for Alzheimer's disease.

Cheng X, Shen Y, Li R.

Drug Discov Today. 2014 Nov;19(11):1822-1827. doi: 10.1016/j.drudis.2014.06.029. Epub 2014 Jul 4. Review.

PMID:
24998784

Supplemental Content

Support Center